8Aoki A, Kifino Y, Ishigatsubo Y, et al. Liver involvement in primary Sjogren' s syndrome. Nihon Rinsho Meneki Gakkai Kaishi,2004,27 (6) :397 -401. 被引量：1
9Ramos - Casals M, Sdnchez - Tapias JM, Par6s A, et al. Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sj? gren ' s syndrome. J Rheumatol. , 2006,33 ( 8 ) : 1593 - 1599. 被引量：1
10Berg PA,Klein R. Antimitochondrial antibodies in primary biliary cirrhosis and other disorders:definition and clinical relevance. Dig Dis, 1992,10(2) :85 - 101. 被引量：1
3Vitali C, Bombardieri S, Jonsson R ,et al. Classification criteria for sjogren' syndrome:A revised version of the Europeancriteria proposed by the American-European consensus group[J].Ann Rheum Dis ,2002,61(6):554-558. 被引量：1
5Berg PA, Klein R. Antimitochondrial antibodies in primary biliary cirrhosis and other disorders: Definition and clinical relevance[J].Dig Dis, 1992,10(2):85-101. 被引量：1
6Czaja AJ, Carpenter HA, Santrach PJ, et al. Autoimmune cholangitis within the spectrum of autoimmune liver di- sease[J].Hepatology, 2000,31(6):1 231-1 238. 被引量：1
8Dorner T, Feist E, Held C, et al. Differential recognition of the 52 KD Ro(SSA) antigen by sera from patients with pri- mary biliary cirrhosis and primary Sjogren's syndrome[J].Hepatology, 1996,24(6):1 404-1 407. 被引量：1
9Lee YM, Kaplan MM. Efficacy of colchicines in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate[J]. Am J Gastroenterol, 2003,98(1):205-208. 被引量：1
10Leuschner M, Holtmeier J, Ackermann H, et al. The in- fluence of Sulindac on patients with primary biliary cirrhosis that responds incompletely to ursodeoxycholic acid: A pilot study[J]. Eur J Gastroenterol Hepatol, 2002,14(12): 1 369-1 376. 被引量：1
2Muller WA. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response [ J ]. Trends in immunology,2003,24 ( 6 ) : 327-334. 被引量：1
3Mobner R, Fassbender K, Kuhnen J, et al. Vascular cell edhesion molecule-a new approach to detect endothelial cell activation in MS and encephalitis in vivo [ J ]. Acta Neurol Scand, 1996,93 ( 2 ) : 118-122. 被引量：1
4Aurrand-Lions M, Johnson-Leger C, Imhof BA. The last molecule fortress in leukocyte trans-endothelial migration [ J ]. Nature immunology,2002,3 (2) : 116-118. 被引量：1
5Mandell KJ, McCall IC, Parkos CA. Involvement of the junctional adhesion molecule-1 ( JAM1 ) homodimer interface in regulation of epithelial barrier function[ J ]. J Biol Chem ,2004,279(16) : 16254-16262. 被引量：1
6Bradfield PF, Nourshargh S, Aurrand-Lions M, et al. JAM family and related proteins in leukocyte migration [ J ]. Arterioscler Thromb Vasc Biol,2007,27 (10) :2104-2112. 被引量：1
7Rossi B, Constantin G. Anti-selectin therapy for the treatment of inflammatory diseases [ J ]. Inflamm Allergy-Drug Targets, 2008,7 ( 2 ) : 85-93. 被引量：1
